申请人:Rigel Pharmaceuticals, Inc.
公开号:US07879856B2
公开(公告)日:2011-02-01
Diaminothiazoles and pharmaceutical compositions containing them are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the diaminothiazoles in treating diseases or conditions associated with Axl activity are also disclosed.
本发明公开了含有二氨基噻唑的药物组合物,这些组合物可用于抑制受体蛋白酪氨酸激酶Axl的活性。还公开了使用二氨基噻唑治疗与Axl活性相关的疾病或症状的方法。